Novavax, Inc.
NVAX
Market Cap$544.42M
Close$
$24.78
527.5% upside
Current Fair Value
527.5% upsideUndervalued by 527.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $544.42 Million |
|---|---|
| Enterprise Value | $204.99 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-5.41 |
| Beta | 1.21 |
| Outstanding Shares | 139,953,143 |
| Avg 30 Day Volume | 3,859,112 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -1.0 |
|---|---|
| PEG | 47.16 |
| Price to Sales | 0.56 |
| Price to Book Ratio | -0.66 |
| Enterprise Value to Revenue | 0.21 |
| Enterprise Value to EBIT | -0.36 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.12 |
| Debt to Equity | -0.32 |
Revenue Sources
No data
ESG Score
No data
About Novavax, Inc.
CEO: Stanley Erck